S&P 500
(0.24%) 5 261.05 points
Dow J
(0.18%) 39 833 points
Nasdaq
(0.04%) 16 406 points
Oil
(2.05%) $83.02
Gas
(1.80%) $1.749
Gold
(1.23%) $2 239.90
Silver
(0.81%) $24.95
Platinum
(1.32%) $921.70
USD/EUR
(0.39%) $0.927
USD/NOK
(0.80%) $10.86
USD/GBP
(0.13%) $0.792
USD/RUB
(0.20%) $92.62

Realtime updates for Dawnrays Pharmaceutical [2348.HK]

Exchange: HKSE Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated28 Mar 2024 @ 04:08

-2.50% HKD 1.170

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 04:08):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally...

Stats
Today's Volume 740 000
Average Volume 292 244
Market Cap 1.76B
EPS HKD0 ( 2023-08-25 )
Last Dividend HKD0.0150 ( 2023-09-19 )
Next Dividend HKD0 ( N/A )
P/E 4.88
ATR14 HKD0.0120 (1.03%)

Volume Correlation

Long: 0.02 (neutral)
Short: 0.39 (neutral)
Signal:(50.14) Neutral

Dawnrays Pharmaceutical Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Dawnrays Pharmaceutical Correlation - Currency/Commodity

The country flag 0.47
( neutral )
The country flag 0.38
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.32
( neutral )

Dawnrays Pharmaceutical Financials

Annual 2022
Revenue: HKD1.28B
Gross Profit: HKD766.68M (60.01 %)
EPS: HKD0.240
Q2 2023
Revenue: HKD649.92M
Gross Profit: HKD356.04M (54.78 %)
EPS: HKD0.170
Q4 2022
Revenue: HKD654.20M
Gross Profit: HKD378.33M (57.83 %)
EPS: HKD0.120
Q2 2022
Revenue: HKD623.48M
Gross Profit: HKD388.35M (62.29 %)
EPS: HKD0.110

Financial Reports:

No articles found.

Dawnrays Pharmaceutical Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0.0150
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0.0730
(N/A)
HKD0.0150
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

Dawnrays Pharmaceutical Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.80 - good (97.95%) | Divividend Growth Potential Score: 7.54 - Increase likely (50.76%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend HKD0.00750 2003-10-17
Last Dividend HKD0.0150 2023-09-19
Next Dividend HKD0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 40 --
Total Paid Out HKD0.998 --
Avg. Dividend % Per Year 0.00% --
Score 3.5 --
Div. Sustainability Score 9.80
Div.Growth Potential Score 7.54
Div. Directional Score 8.67 --
Next Divdend (Est)
(2024-07-03)
HKD0.0131 Estimate 12.38 %
Dividend Stability
0.50 Below Average
Dividend Score
3.50
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Warning: Undefined variable $stockPricesArray in /home/getagraph/public_html/stock.php on line 1111

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
3958.HK Ex Dividend Junior 2023-05-23 Annually 0 0.00%
1795.HK Ex Dividend Junior 2023-06-30 Annually 0 0.00%
0836.HK Ex Dividend Knight 2023-09-05 Semi-Annually 0 0.00%
0006.HK Ex Dividend Knight 2023-08-30 Semi-Annually 0 0.00%
2368.HK Ex Dividend Knight 2023-08-25 Semi-Annually 0 0.00%
1368.HK Ex Dividend Knight 2023-09-05 Semi-Annually 0 0.00%
0436.HK Ex Dividend Junior 2023-06-02 Annually 0 0.00%
6668.HK Ex Dividend Knight 2023-06-13 Annually 0 0.00%
1908.HK Ex Dividend Junior 2023-06-01 Sporadic 0 0.00%
0952.HK No Dividend Player 2023-09-14 Sporadic 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.3391.5003.224.82[0 - 0.5]
returnOnAssetsTTM0.1241.2005.867.03[0 - 0.3]
returnOnEquityTTM0.1621.5009.3110.00[0.1 - 1]
payoutRatioTTM0.263-1.0007.37-7.37[0 - 1]
currentRatioTTM2.590.8002.061.652[1 - 3]
quickRatioTTM1.9290.8003.362.69[0.8 - 2.5]
cashRatioTTM1.1551.5004.707.04[0.2 - 2]
debtRatioTTM0.00940-1.5009.84-10.00[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM0.2382.009.9210.00[0 - 30]
freeCashFlowPerShareTTM0.1032.009.9510.00[0 - 20]
debtEquityRatioTTM0.0119-1.5009.95-10.00[0 - 2.5]
grossProfitMarginTTM0.5631.0003.953.95[0.2 - 0.8]
operatingProfitMarginTTM0.2891.0006.226.22[0.1 - 0.6]
cashFlowToDebtRatioTTM10.681.00010.0010.00[0.2 - 2]
assetTurnoverTTM0.3670.800-0.889-0.711[0.5 - 2]
Total Score9.80

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM3.671.0009.730[1 - 100]
returnOnEquityTTM0.1622.509.5510.00[0.1 - 1.5]
freeCashFlowPerShareTTM0.1032.009.9710.00[0 - 30]
dividendYielPercentageTTM8.151.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM0.2382.009.9210.00[0 - 30]
payoutRatioTTM0.2631.5007.37-7.37[0 - 1]
pegRatioTTM0.6361.5009.090[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2741.0005.650[0.1 - 0.5]
Total Score7.54

Dawnrays Pharmaceutical

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators